Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 297671, 11 pages
http://dx.doi.org/10.1155/2010/297671
Research Article

Germline Mutations and Polymorphisms in the Origins of Cancers in Women

1The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
2Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
3Institute for Advanced Study, Princeton, NJ 08540, USA

Received 23 June 2009; Accepted 14 November 2009

Academic Editor: Tian-Li Wang

Copyright © 2010 Kim M. Hirshfield et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Michael H. Roh, Yosuf Yassin, Alexander Miron, Karishma K. Mehra, Mitra Mehrad, Nicolas M. Monte, George L. Mutter, Marisa R. Nucci, Geng Ning, Frank D. Mckeon, Michelle S. Hirsch, Xian Wa, and Christopher P. Crum, “High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression,” Modern Pathology, vol. 23, no. 10, pp. 1316–1324, 2010. View at Publisher · View at Google Scholar
  • Erin W. Hofstatter, Susan M. Domchek, Alexander Miron, Judy Garber, Molin Wang, Kathryn Componeschi, Leigh Boghossian, Penelope L. Miron, Katherine L. Nathanson, and Nadine Tung, “PALB2 mutations in familial breast and pancreatic cancer,” Familial Cancer, vol. 10, no. 2, pp. 225–231, 2011. View at Publisher · View at Google Scholar
  • Valentina Silvestri, Laura Ottini, Piera Rizzolo, and Mario Falchetti, “Inherited and acquired alterations in development of breast cancer,” Application of Clinical Genetics, vol. 4, pp. 145–158, 2011. View at Publisher · View at Google Scholar
  • Blanka Sharma, Wenxue Ma, Isaac Morris Adjei, Jayanth Panyam, Sanja Dimitrijevic, and Vinod Labhasetwar, “Nanoparticle-mediated p53 gene therapy for tumor inhibition,” Drug Delivery and Translational Research, vol. 1, no. 1, pp. 43–52, 2011. View at Publisher · View at Google Scholar
  • Amanda Goncalves Silva, Ingrid Petroni Ewald, Marina Sapienza, Manuela Pinheiro, Ana Peixoto, Amanda Frana de Nobrega, Dirce M. Carraro, Manuel R. Teixeira, Patricia Ashton-Prolla, Maria Isabel W. Achatz, Carla Rosenberg, and Ana C. V. Krepischi, “Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion ,” Bmc Cancer, vol. 12, 2012. View at Publisher · View at Google Scholar
  • D. Fanale, V. Amodeo, L. R. Corsini, S. Rizzo, V. Bazan, and A. Russo, “Breast cancer genome-wide association studies: there is strength in numbers,” Oncogene, vol. 31, no. 17, pp. 2121–2128, 2012. View at Publisher · View at Google Scholar
  • Ana C. V. Krepischi, Maria Isabel W. Achatz, Erika M. M. Santos, Silvia S. Costa, Bianca C. G. Lisboa, Helena Brentani, Tiago M. Santos, Amanda Goncalves, Amanda F. Nobrega, Peter L. Pearson, Angela M. Vianna-Morgante, Dirce M. Carraro, Ricardo R. Brentani, and Carla Rosenberg, “Germline DNA copy number variation in familial and early-onset breast cancer,” Breast Cancer Research, vol. 14, no. 1, 2012. View at Publisher · View at Google Scholar
  • Nikoleta Poumpouridou, and Christos Kroupis, “Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 3, pp. 423–434, 2012. View at Publisher · View at Google Scholar
  • Sonam Tulsyan, Pankaj Chaturvedi, Gaurav Agarwal, Punita Lal, Sushma Agrawal, Rama Devi Mittal, and Balraj Mittal, “Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach,” Molecular Diagnosis & Therapy, 2013. View at Publisher · View at Google Scholar
  • Ying-Yu Ma, Tian-Pei Guan, Hai-Bo Yao, Sheng Yu, Le-Gao Chen, Ying-Jie Xia, Xu-Jun He, Hui-Ju Wang, Xiao-Ting Jiang, and Hou-Quan Tao, “The MDM2 309T > G Polymorphism and Ovarian Cancer Risk: A Meta-Analysis of 1534 Cases and 2211 Controls,” Plos One, vol. 8, no. 1, 2013. View at Publisher · View at Google Scholar
  • Jessica Teh, Suzie Chen, Kim M. Hirshfield, Sonia C. Dolfi, Yong Lin, Madhura S. Mehta, Romona D. Kersellius, Dan J. Medina, Shridar Ganesan, Hussein Rahim, Erhan Bilal, Seena Aisner, Deborah L. Toppmeyer, Alexei Vazquez, Roman Bronfenbrener, Chunxia Chen, and Dirk Moore, “Metabotropic Glutamate Receptor 1 Expression and Its Polymorphic Variants Associate with Breast Cancer Phenotypes,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Evangelos Kostantinopoulos, Jean-Christophe Nebel, George P. Patrinos, Haralabos P. Kalofonos, Zoi Lanara, Efstathia Giannopoulou, Marta Fullen, and Cristiana Pavlidis, “Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection,” Human Genomics, vol. 7, 2013. View at Publisher · View at Google Scholar
  • Chandrababu Rejeeth, and Soundrapandian Kannan, “p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles,” Breast Cancer, 2014. View at Publisher · View at Google Scholar
  • Oskar T. Johannsson, Niklas Loman, Martin P. Nilsson, Linda Hartman, Ingrid Idvall, and Ulf Kristoffersson, “Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Anukriti Singh, Jessica J. Nunes, and Bushra Ateeq, “Role and therapeutic potential of G-protein coupled receptors in breast Cancer progression and metastases,” European Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Godfrey Grech, Xianquan Zhan, Byong Chul Yoo, Rostyslav Bubnov, Suzanne Hagan, Romano Danesi, Giorgio Vittadini, and Dominic M Desiderio, “EPMA position paper in cancer: current overview and future perspectives,” EPMA Journal, vol. 6, no. 1, 2015. View at Publisher · View at Google Scholar
  • Weiwei Shan, Chao Wang, Zhenbo Zhang, Xuezhen Luo, Chengcheng Ning, Yinhua Yu, Youji Feng, Chao Gu, and Xiaojun Chen, “ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Li Yang, Ya-Jun Wang, Li-Yuan Zheng, Yu-Mian Jia, Yi-Lin Chen, Lan Chen, Dong-Ge Liu, Xiang-Hong Li, Hong-Yan Guo, Ying-Li Sun, Xin-Xia Tian, and Wei-Gang Fang, “Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women,” Plos One, vol. 11, no. 5, 2016. View at Publisher · View at Google Scholar
  • Subhasree Basu, and Maureen E. Murphy, “Genetic Modifiers of the p53 Pathway,” Cold Spring Harbor Perspectives In Medicine, vol. 6, no. 4, 2016. View at Publisher · View at Google Scholar
  • Xiangzhen Kong, Zihao Li, and Xian Li, “GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis,” Cancer Chemotherapy and Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Meng-Yun Wang, Jing He, Mei-Ling Zhu, Xiao-Yan Teng, Qiao-Xin Li, Meng-Hong Sun, Xiao-Feng Wang, Ya-Jun Yang, Jiu-Cun Wang, Li Jin, Ya-Nong Wang, and Qing-Yi Wei, “A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population,” Scientific Reports, vol. 6, pp. 20008, 2016. View at Publisher · View at Google Scholar
  • Serena Bertozzi, Ambrogio P Londero, Luca Seriau, Roberta Di Vora, Carla Cedolini, and Laura Mariuzzi, “Biomarkers in Breast Cancer,” Biomarker - Indicator of Abnormal Physiological Process, 2018. View at Publisher · View at Google Scholar